Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Study Association trial

Published 2013 View Full Article

Authors

Keywords

Journal

HAEMATOLOGICA

Volume 98, Issue 11, Pages 1726-1731

Publisher

Ferrata Storti Foundation (Haematologica)

Online

2013-06-11

DOI

10.3324/haematol.2013.090597

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

HAEMATOLOGICA

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Add your recorded webinar

Become a Peeref-certified reviewer